Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

Clinical trial NCT06585514 · RECRUITING

Trial details

NCT number: NCT06585514
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)

Start date: 2024-10-17
Primary completion: 2026-09-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.